Mapping the coevolution, leadership and financing of research on viral vectors, RNAi, CRSPR/Cas9 and other genomic editing technologies

作者: David Fajardo Ortiz , Annie Shattuck , Stefan Hornbostel

DOI: 10.1101/2019.12.24.887893

关键词: Process (engineering)European unionCas9BiomedicineTranscription activator-like effector nucleaseGovernmentApplied researchFinanceCRISPRBusiness

摘要: In the present investigation, we set out to determine and compare evolution of research on viral vectors, RNAi genomic editing platforms as well profile main institutions funding agencies. A search papers vectors RNAi, CRISPR/Cas, TALENs, ZFNs meganucleases was carried in Web Science. citation network 16,746 constructed. An analysis clustering combined with text mining performed. case a long term process incremental innovation which clusters are organized around specific improvements clinical relevance identified. The most influential investigations were conducted United States European Union where funders government trajectory included related study biological phenomenon its use functional genomics, biomedicine pest control. British philanthropic organization US pharmaceutical company played key role development basic application respectively, addition agencies academic institutions. CRISPR/Cas research, science discoveries led technical improvements, these two turn provided information required for biomedical, agricultural, livestock industrial applications. exhibits geopolitical division investigation efforts between US, producer China increasingly leading applied research. foundations stages Our results reflect change model financing emergence scientific superpower, implications applications technologies.

参考文章(47)
Sujin Choi, Joshua SungWoo Yang, Han Woo Park, The triple helix and international collaboration in science Journal of the Association for Information Science and Technology. ,vol. 66, pp. 201- 212 ,(2015) , 10.1002/ASI.23165
Chun-xiao Li, Hai-li Qian, A double-edged sword: CRISPR-Cas9 is emerging as a revolutionary technique for genome editing Military Medical Research. ,vol. 2, pp. 25- 25 ,(2015) , 10.1186/S40779-015-0054-1
LinLin Zhang, Qi Zhou, CRISPR/Cas technology: a revolutionary approach for genome engineering Science China Life Sciences. ,vol. 57, pp. 639- 640 ,(2014) , 10.1007/S11427-014-4670-X
Victor Castaño, David Fajardo, Luis Duran, Laura Moreno, Hector Ochoa, Liposomes versus metallic nanostructures: differences in the process of knowledge translation in cancer. International Journal of Nanomedicine. ,vol. 9, pp. 2627- 2634 ,(2014) , 10.2147/IJN.S62315
Linda B Couto, Katherine A High, Viral vector-mediated RNA interference. Current Opinion in Pharmacology. ,vol. 10, pp. 534- 542 ,(2010) , 10.1016/J.COPH.2010.06.007
R. Barrangou, Cas9 targeting and the CRISPR revolution Science. ,vol. 344, pp. 707- 708 ,(2014) , 10.1126/SCIENCE.1252964
Anne Pollock, Transforming the critique of Big Pharma Biosocieties. ,vol. 6, pp. 106- 118 ,(2011) , 10.1057/BIOSOC.2010.44
Lionel Spinelli, Philippe Gambette, Charles E. Chapple, Benoît Robisson, Anaïs Baudot, Henri Garreta, Laurent Tichit, Alain Guénoche, Christine Brun, Clust&See: a Cytoscape plugin for the identification, visualization and manipulation of network clusters. BioSystems. ,vol. 113, pp. 91- 95 ,(2013) , 10.1016/J.BIOSYSTEMS.2013.05.010
David Benjamin Turitz Cox, Randall Jeffrey Platt, Feng Zhang, Therapeutic genome editing: prospects and challenges. Nature Medicine. ,vol. 21, pp. 121- 131 ,(2015) , 10.1038/NM.3793